1. Home
  2. NMRA vs SERV Comparison

NMRA vs SERV Comparison

Compare NMRA & SERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • SERV
  • Stock Information
  • Founded
  • NMRA 2019
  • SERV 2017
  • Country
  • NMRA United States
  • SERV United States
  • Employees
  • NMRA N/A
  • SERV 121
  • Industry
  • NMRA
  • SERV Industrial Specialties
  • Sector
  • NMRA
  • SERV Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • SERV Nasdaq
  • Market Cap
  • NMRA 287.6M
  • SERV 310.2M
  • IPO Year
  • NMRA 2023
  • SERV N/A
  • Fundamental
  • Price
  • NMRA $0.65
  • SERV $5.45
  • Analyst Decision
  • NMRA Buy
  • SERV Strong Buy
  • Analyst Count
  • NMRA 8
  • SERV 3
  • Target Price
  • NMRA $9.29
  • SERV $17.00
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • SERV 3.8M
  • Earning Date
  • NMRA 05-06-2025
  • SERV 05-14-2025
  • Dividend Yield
  • NMRA N/A
  • SERV N/A
  • EPS Growth
  • NMRA N/A
  • SERV N/A
  • EPS
  • NMRA N/A
  • SERV N/A
  • Revenue
  • NMRA N/A
  • SERV $1,812,483.00
  • Revenue This Year
  • NMRA N/A
  • SERV $559.21
  • Revenue Next Year
  • NMRA N/A
  • SERV $386.65
  • P/E Ratio
  • NMRA N/A
  • SERV N/A
  • Revenue Growth
  • NMRA N/A
  • SERV 773.30
  • 52 Week Low
  • NMRA $0.62
  • SERV $1.77
  • 52 Week High
  • NMRA $17.19
  • SERV $24.35
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 22.34
  • SERV N/A
  • Support Level
  • NMRA $0.64
  • SERV N/A
  • Resistance Level
  • NMRA $0.83
  • SERV N/A
  • Average True Range (ATR)
  • NMRA 0.09
  • SERV 0.00
  • MACD
  • NMRA 0.02
  • SERV 0.00
  • Stochastic Oscillator
  • NMRA 6.68
  • SERV 0.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About SERV Serve Robotics Inc. Common Stock

Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.

Share on Social Networks: